Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia-Reference-Cited by-同舟云学术

Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia

Published:2015-05-29 Issue:17 Volume:121 Page:2900-2908
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gronseth Christine M.¹,McElhone Scott E.¹,Storer Barry E.²,Kroeger Kathleen A.¹,Sandhu Vicky³,Fero Matthew L.³⁴⁵,Appelbaum Frederick R.³⁴⁵,Estey Elihu H.³⁴⁵,Fang Min³⁶⁵

Affiliation:

1. Cytogenetics Department, Seattle Cancer Care Alliance; Seattle Washington

2. Clinical Statistics Department, Fred Hutchinson Cancer Research Center; Seattle Washington

3. Clinical Research Division, Fred Hutchinson Cancer Research Center; Seattle Washington

4. Department of Medicine; University of Washington; Seattle Washington

5. Seattle Cancer Care Alliance; Seattle Washington

6. Department of Pathology; University of Washington; Seattle Washington

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29475/fullpdf

Reference23 articles.

1. Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia;Mrozek;J Clin Oncol,2012

2. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study;Slovak;Blood,2000

3. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties;Grimwade;Blood,1998

4. Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation;Fang;Blood,2011

5. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype;Breems;J Clin Oncol,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications;International Journal of Molecular Sciences;2024-08-08

2. Evaluation of Acute Myeloid Leukemia Genomes using Genomic Proximity Mapping;2024-06-01

3. Section E6.1–6.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone marrow, and lymph nodes;Genetics in Medicine;2024-04

4. Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic Strategies;Frontiers in Oncology;2021-09-30

5. Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia;Scientific Reports;2021-07-22